Virtu Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Buy |
+146,805
| New | +$139K | 0.01% | 986 |
|
|
2025
Q1 | – | Sell |
-88,982
| Closed | -$66K | – | 1743 |
|
|
2024
Q4 | $66K | Buy |
+88,982
| New | +$66K | ﹤0.01% | 1109 |
|
|
2024
Q2 | – | Sell |
-43,591
| Closed | -$105K | – | 1639 |
|
|
2024
Q1 | $105K | Buy |
+43,591
| New | +$105K | 0.01% | 918 |
|
|
2023
Q3 | – | Sell |
-19,948
| Closed | -$46K | – | 1637 |
|
|
2023
Q2 | $46K | Sell |
19,948
-1,781
| -8% | -$4.11K | ﹤0.01% | 1148 |
|
|
2023
Q1 | $53K | Buy |
+21,729
| New | +$53K | 0.01% | 1084 |
|
|
2022
Q4 | – | Sell |
-13,458
| Closed | -$32K | – | 1936 |
|
|
2022
Q3 | $32K | Buy |
+13,458
| New | +$32K | ﹤0.01% | 1301 |
|
|
2020
Q3 | – | Sell |
-69,282
| Closed | -$138K | – | 1324 |
|
|
2020
Q2 | $138K | Buy |
+69,282
| New | +$138K | 0.02% | 806 |
|
|
2019
Q2 | – | Sell |
-35,164
| Closed | -$196K | – | 1668 |
|
|
2019
Q1 | $196K | Buy |
+35,164
| New | +$196K | 0.01% | 1005 |
|
|
2017
Q4 | – | Sell |
-11,993
| Closed | -$147K | – | 2723 |
|
|
2017
Q3 | $147K | Buy |
+11,993
| New | +$147K | 0.01% | 1970 |
|
|
2014
Q2 | – | Sell |
-2,398
| Closed | -$29K | – | 385 |
|
|
2014
Q1 | $29K | Buy |
+2,398
| New | +$29K | ﹤0.01% | 374 |
|